Growth factors in pancreatic health and disease

被引:16
作者
Balaz, P [1 ]
Friess, H [1 ]
Büchler, MW [1 ]
机构
[1] Univ Bern, Inselspital, Dept Visceral & Transplantat Surg, CH-3010 Bern, Switzerland
关键词
growth factors; growth factor receptors; chronic pancreatitis; pancreatic cancer;
D O I
10.1159/000055833
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In this article the role of different growth factors and their receptors in the pathogenesis of chronic pancreatitis and pancreatic cancer is discussed. The expression of members of the epidermal growth factor family, the fibroblast growth factor family, the transforming growth factor-beta family, the platelet-derived growth factor family, the nerve growth factor family, the insulin-like growth factor family and their signaling receptors is presented, and a correlation of the molecular data with clinical and pathological changes is performed. A number of these growth factors and their receptors are markedly overexpressed in chronic pancreatitis and pancreatic cancer. In chronic pancreatitis, overexpression of growth factors and their receptors contributes to tissue remodeling and fibrogenesis. In contrast to chronic pancreatitis, pancreatic cancer is associated with a variety of genetic alterations, including mutations in tumor suppressor genes and cell cycle regulators. In the presence of these genetic disturbances, enhanced expression of growth factors and their receptors contributes to cell proliferation and enhances the aggressiveness of pancreatic cancer cells. In summary, growth factors and their receptors are often altered in chronic pancreatitis and pancreatic cancer and contribute to various pathogenetic aspects in these disorders. Copyright (C) 2001 S. Karger AG, Basel and IAP.
引用
收藏
页码:343 / 355
页数:13
相关论文
共 168 条
  • [1] Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis
    Apte, MV
    Haber, PS
    Darby, SJ
    Rodgers, SC
    McCaughan, GW
    Korsten, MA
    Pirola, RC
    Wilson, JS
    [J]. GUT, 1999, 44 (04) : 534 - 541
  • [2] Baldassarre G, 1996, INT J CANCER, V66, P538, DOI 10.1002/(SICI)1097-0215(19960516)66:4<538::AID-IJC19>3.0.CO
  • [3] 2-3
  • [4] Baldwin RL, 1996, INT J CANCER, V67, P283, DOI 10.1002/(SICI)1097-0215(19960717)67:2<283::AID-IJC21>3.0.CO
  • [5] 2-B
  • [6] NEUROTROPHIC FACTORS AND THEIR RECEPTORS
    BARBACID, M
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (02) : 148 - 155
  • [7] BARTON CM, 1991, J PATHOL, V163, P111, DOI 10.1002/path.1711630206
  • [8] THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES
    BASILICO, C
    MOSCATELLI, D
    [J]. ADVANCES IN CANCER RESEARCH, 1992, 59 : 115 - 165
  • [9] BERGMANN U, 1995, CANCER RES, V55, P2007
  • [10] Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R) -: Clinical relevance in pancreatic cancer and chronic pancreatitis
    Birk, D
    Gansauge, F
    Gansauge, S
    Formentini, A
    Lucht, A
    Beger, HG
    [J]. INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1999, 25 (02) : 89 - 96